Glucocorticoid & Chronic-Disease Hypogonadism
Illness- and steroid-related suppression of the testosterone axis
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Not a product; an effect of glucocorticoids and systemic illness
Reference only. Not medical advice.
This is something to take to a clinician. The Atlas can tell you what is known about glucocorticoid & chronic-disease hypogonadism in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Both chronic glucocorticoid therapy and serious systemic illness can suppress testosterone. Glucocorticoids, whether from prescribed steroids or the body's own cortisol surge during critical illness, inhibit hypothalamic GnRH (and can act lower in the axis), reducing LH, FSH and testosterone. Acute and chronic illness add inflammatory cytokine effects, producing a functional secondary hypogonadism. The pattern is generally reversible as the steroid is tapered or the underlying illness resolves, so it is often best not treated as permanent low-T.
Sickness and steroids both turn the testosterone dial down.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
Glucocorticoids suppress hypothalamic GnRH secretion and can blunt pituitary and gonadal responses, lowering LH, FSH and testosterone. In critical illness, sustained high glucocorticoid availability exerts negative feedback at the hypothalamus and pituitary, and inflammatory cytokines further inhibit the gonadal axis. The result is a functional, hypogonadotropic suppression rather than a fixed structural defect.
Why timing of the blood draw matters
This is a classic reason NOT to diagnose hypogonadism from a single testosterone drawn during illness. Levels measured during acute infection, hospitalization or a steroid course can be transiently low and recover afterward. Endocrine guidance is to avoid diagnosing and treating low-T in the setting of acute or subacute illness, repeating measurement after recovery.
Safety in detail
Glucocorticoids are powerful prescription medicines with broad effects; dose changes must be managed by the prescriber, and abrupt withdrawal of long-term steroids is dangerous. Low testosterone in this context should be interpreted cautiously and re-evaluated after recovery rather than reflexively treated.
What it does to fertility
Functional suppression of LH and FSH can transiently impair spermatogenesis, but because the cause is reversible, fertility typically recovers as glucocorticoids are tapered or illness resolves. Exogenous testosterone would suppress the axis further and is generally not the first move.
What has to be monitored
The bloodwork this needs, and the reason it belongs with a clinician rather than a website.
- Total testosterone with LH and FSH (repeat after recovery)
- Review of glucocorticoid dose and duration
- Markers of the underlying illness/inflammation
- Bone density with prolonged steroid use
What people get wrong
Often saidA low testosterone during my hospital stay means I have hypogonadism
ActuallyNot necessarily. Acute illness and glucocorticoids transiently suppress the axis; guidelines advise re-measuring after recovery before diagnosing.
Often saidSteroid-related low-T is permanent
ActuallyIt is usually functional and tends to recover as the glucocorticoid is tapered or the illness resolves.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
At a glance
- Steroid effect
- Chronic glucocorticoids reduce testosterone, partly via GnRH suppression
- Illness effect
- Cytokines plus high endogenous cortisol suppress the axis
- Course
- Often reversible as steroids taper or illness resolves
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Glucocorticoid & Chronic-Disease Hypogonadism. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What can go wrong. We have not written the risk line for this one. Read the safety section below rather than treating its absence as reassurance.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Reduction of serum testosterone during chronic glucocorticoid therapy, Annals of Internal Medicine1986
Chronic glucocorticoids lowered serum testosterone, attributed in part to altered hypothalamic GnRH secretion
Reviews of critical-illness endocrinologyvarious
Describe suppression of the gonadal axis by high endogenous glucocorticoids and inflammatory cytokines during severe illness